Extraordinary Measures (film)

Last updated

Extraordinary Measures
Extraordinary measures poster.jpg
Theatrical release poster
Directed by Tom Vaughan
Written by Robert Nelson Jacobs
Based onThe Cure: How a Father Raised $100 Million — And Bucked the Medical Establishment — in a Quest to Save His Children
by Geeta Anand
Produced by
Starring
Cinematography Andrew Dunn
Edited by Anne V. Coates
Music by Andrea Guerra
Production
company
Double Feature Films
Distributed by CBS Films (North America)
Sony Pictures Releasing International (International) [1] [2]
Release date
  • January 22, 2010 (2010-01-22)
Running time
106 minutes
CountryUnited States
LanguageEnglish
Budget$31 million [3]
Box office$15 million [3]

Extraordinary Measures is a 2010 American medical drama film starring Brendan Fraser, Harrison Ford, and Keri Russell. It was the first film produced by CBS Films, the film division of CBS Corporation, who released the film on January 22, 2010. The film is about parents who form a biotechnology company to develop a drug to save the lives of their children, who have a life-threatening disease. The film is based on the true story of John and Aileen Crowley, whose children have Pompe disease. The film was shot in St. Paul, Oregon; Portland, Oregon; Tualatin, Oregon; Wilsonville, Oregon; Manzanita, Oregon; Beaverton, Oregon, and Vancouver, Washington.

Contents

Plot

John Crowley and his wife Aileen are a Portland couple with two of their three children suffering from Pompe disease, a genetic anomaly that typically kills most children before their tenth birthdays. John, an advertising executive, contacts Robert Stonehill, a researcher in Nebraska who has done innovative research for an enzyme treatment for the rare disease. John and Aileen raise money to help Stonehill's research and the required clinical trials.

John takes on the task full-time to save his children's lives, launching a biotechnology research company working with venture capitalists and then rival teams of researchers. This task proves very daunting for Stonehill, who already works around the clock. As time is running short, Stonehill's angry outburst hinders the company's faith in him, and the profit motive may upend John's hopes. The researchers race against time to save the children who have the disease.

Cast

John Crowley makes a cameo appearance as a venture capitalist.

Production

Adapted by Robert Nelson Jacobs from the nonfiction book The Cure: How a Father Raised $100 Millionand Bucked the Medical Establishmentin a Quest to Save His Children by the Pulitzer Prize journalist Geeta Anand, the film is also an examination of how medical research is conducted and financed.

Filming in May 2009 at Pioneer Courthouse Square in Portland, Oregon Filming of Extraordinary Measures in Portland, Oregon.JPG
Filming in May 2009 at Pioneer Courthouse Square in Portland, Oregon

Filming took place at several spots in and around Portland, Oregon, mostly at the OHSU Doernbecher Children's Hospital, Veterans Affairs Medical Center and the Nike campus in Beaverton, Oregon. This was the first time Nike allowed filming on their campus and they donated the location payment to Doernbecher Children’s Hospital. [4] During filming, the working title was The Untitled Crowley Project. [5]

In the film, the children are 9 and 7 years old. Their non-fiction counterparts were diagnosed at 15 months and 7 days old and received treatment at 5 and 4, respectively. [6]

Inspiration

Myozyme, a drug developed for treating Pompe disease, was simultaneously approved for sale by the US Food and Drug Administration and the European Medicines Agency. Henceforth, more than 1000 infants born worldwide every year with Pompe disease will no longer face the prospect of death before reaching their first birthday for lack of a treatment for the condition.

The screenplay by Robert Nelson Jacobs is based on Geeta Anand's book The Cure ( ISBN   9780060734398). [7] Parts of the book first appeared as a series of articles in The Wall Street Journal .

The small start-up company Priozyme was based on Oklahoma City-based Novazyme. The larger company, called Zymagen in the film, was based on Genzyme in Cambridge, Massachusetts. [8] Novazyme was developing a protein therapeutic, with several biological patents pending, to treat Pompe Disease, when it was bought by Genzyme. The patent portfolio was cited in the press releases announcing the deal. [9]

Genzyme claims that Dr. Robert Stonehill's character is based upon scientist and researcher William Canfield, [10] who founded Novazyme. [11] According to Roger Ebert's review, the character is based on Yuan-Tsong Chen, [6] a scientist and researcher from Duke University [12] who collaborated with Genzyme in producing Myozyme, the drug which received FDA approval.

Reception

Critical response

Review aggregation website Rotten Tomatoes gives Extraordinary Measures an approval rating of 29% based on reviews from 142 critics and an average rating of 4.88 out of 10. The site's general consensus is, "Despite a timely topic and a pair of heavyweight leads, Extraordinary Measures never feels like much more than a made-for-TV tearjerker." [13] Metacritic, which assigns a weighted average score out of 0–100 reviews from film critics, has a rating score of 45 based on 33 reviews. [14] Audiences polled by CinemaScore gave the film an average grade of "A-" on an A+ to F scale. [15]

Richard Corliss of Time magazine wrote: "Fraser keeps the story anchored in reality. Meredith Droeger does too: as the Crowleys' afflicted daughter, she's a smart little bundle of fighting spirit. So is the movie, which keeps its head while digging into your heart. You have this critic's permission to cry in public." [16] The New York Times' A. O. Scott said in his review: "The startling thing about Extraordinary Measures is not that it moves you. It's that you feel, at the end, that you have learned something about the way the world works." [17]

Ramona Bates MD, writing for the health news organisation, EmaxHealth, stated that the film brings attention to Pompe disease. [18] Peter Rainer from The Christian Science Monitor mentions that Big Pharma got a surprisingly free pass in the film and that it will come as a surprise to all those sufferers struggling to get orphan drugs developed. [19]

Jef Akst, writing for the journal The Scientist, stated that the film is good depiction of the "hard to swallow fiscal issues of drug development." [20]

Box office

The film opened at #8 on its opening weekend, taking in $6 million. The film remained in theaters for four weeks, earning $12 million.

Related Research Articles

<span class="mw-page-title-main">Keri Russell</span> American actress (born 1976)

Keri Lynn Russell is an American actress. She played the title role in the drama series Felicity (1998–2002), which won her a Golden Globe Award, and later portrayed Elizabeth Jennings in the spy thriller series The Americans (2013–2018), which earned her nominations for several Primetime Emmy and Golden Globe Awards. For playing the title role in the political drama series The Diplomat (2023–present), she received further Primetime Emmy and Golden Globe nominations. She has also received a record six nominations for the Critics' Choice Television Award for Best Actress in a Drama Series.

<span class="mw-page-title-main">Phytochemical</span> Chemical compounds produced by plants

Phytochemicals are chemical compounds produced by plants, generally to help them resist fungi, bacteria and plant virus infections, and also consumption by insects and other animals. The name comes from Greek φυτόν (phyton) 'plant'. Some phytochemicals have been used as poisons and others as traditional medicine.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Glycogen storage disease type II</span> Medical condition

Glycogen storage disease type II(GSD-II), also called Pompe disease, and formerly known as GSD-IIa or Limb–girdle muscular dystrophy2V, is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme (GAA). The inability to breakdown glycogen within the lysosomes of cells leads to progressive muscle weakness throughout the body and affects various body tissues, particularly in the heart, skeletal muscles, liver and the nervous system.

<span class="mw-page-title-main">Joel David Moore</span> American character actor and director (born 1977)

Joel David Moore is an American character actor and director. Born and raised in Portland, Oregon, Moore studied acting in college before relocating to Los Angeles to pursue a film career. His first major role was as Owen Dittman in the 2004 comedy Dodgeball: A True Underdog Story, followed by roles in the comedy Grandma's Boy (2006), Terry Zwigoff's Art School Confidential (2006), and the independent slasher film Hatchet (2006).

Oregon Health & Science University (OHSU) is a public research university focusing primarily on health sciences with a main campus, including two hospitals, in Portland, Oregon. The institution was founded in 1887 as the University of Oregon Medical Department and later became the University of Oregon Medical School. In 1974, the campus became an independent, self-governed institution called the University of Oregon Health Sciences Center, combining state dentistry, medicine, nursing, and public health programs into a single center. It was renamed Oregon Health Sciences University in 1981 and took its current name in 2001, as part of a merger with the Oregon Graduate Institute (OGI), in Hillsboro. The university has several partnership programs including a joint PharmD Pharmacy program with Oregon State University in Corvallis.

<span class="mw-page-title-main">Genzyme</span> Company

Genzyme was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme had a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products were also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America's leading innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi.

<i>Mans Best Friend</i> (1993 film) 1993 film by John Lafia

Man's Best Friend is a 1993 American science fiction horror film, directed and written by John Lafia. It stars Ally Sheedy, Lance Henriksen, Robert Costanzo, Frederic Lehne, John Cassini, and J. D. Daniels.

Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease, a rare lysosomal storage disorder (LSD). Chemically, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.

The Oregon Health Plan is Oregon's state Medicaid program. It is overseen by the Oregon Health Authority.

<span class="mw-page-title-main">John Crowley (businessman)</span> American biotechnology executive and entrepreneur

John Francis Crowley is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. He served as the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010. Crowley was named CEO of the Biotechnology Innovation Organization, the largest Biotechnology advocacy organization in the world, in 2023.

<span class="mw-page-title-main">Cambridge Antibody Technology</span> Defunct British biotechnology company

Cambridge Antibody Technology Group Plc, was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.

William Canfield is a glycobiologist, chief scientific officer and founder of an Oklahoma City-based biotechnology company, Novazyme, which was acquired by Genzyme in August 2001 and developed, among other things, an enzyme that can stabilize Pompe disease, based on Canfield's ongoing research since 1998. Canfield subsequently left Genzyme and established, with his partner in the Novazyme operation, John Crowley, another research laboratory, which he still heads. He saved Cytovance from bankruptcy by forming an investor group and raising $9 million after Crowley suddenly left the lab in 2005 to become the chief executive officer at Amicus Therapeutics in New Jersey

<span class="mw-page-title-main">Dupilumab</span> Drug used to treat allergic diseases

Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis. It is also used for the treatment of eosinophilic esophagitis, prurigo nodularis and COPD.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

<span class="mw-page-title-main">Henri Termeer</span>

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

<span class="mw-page-title-main">Biotechnology Innovation Organization</span> Biotechnology advocacy association

The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on January 4, 2016. Biotechnology Innovation Organization serves more than 1,100 biotechnology firms, research schools, state biotechnology centers and related associations in the United States and in more than 30 other countries.

<span class="mw-page-title-main">Markus Grompe</span>

Markus Grompe is a professor of Pediatrics and practicing physician at Oregon Health & Science University. since 1991. Since 2004, he has been director of the Oregon Stem Cell Center at OHSU. Until 2018, he was also director of the Papé Family Pediatric Research Institute, Vice Chair for research in the OHSU department of Pediatrics, and holder of the Ray Hickey Endowed Chair at Doernbecher Children's Hospital.

Yuan-Tsong Chen is a Taiwanese geneticist and physician, notable for his work on human genetic disorders. He is the director emeritus (2001–2010) and distinguished research fellow (2001–present) of the Institute of Biomedical Sciences, Academia Sinica, Taiwan, and also tenured professor of pediatrics of Duke University (1993–present) Chen was a 2019 awardee of Taiwan's Presidential Science Award, as were Yuan-Pern Lee and Wei Fu-chan.

Avalglucosidase alfa, sold under the brand name Nexviazyme, is an enzyme replacement therapy medication used for the treatment of glycogen storage disease type II.

References

  1. Goodridge, Mike (January 21, 2010). "Extraordinary Measures". Screen International . Retrieved September 19, 2021.
  2. "CBS Films hooks up with Sony". Variety . November 17, 2009. Retrieved September 19, 2021.
  3. 1 2 "Extraordinary Measures (2010)". Box Office Mojo . Internet Movie Database . Retrieved January 25, 2010.
  4. "'Extraordinary Measures,' filmed in Portland and starring Brendan Fraser and Harrison Ford, opens Friday". The Oregonian . Advance Publications. January 21, 2010. Archived from the original on September 23, 2012. Retrieved January 25, 2010.
  5. "On the 'Crowley' set: Boredom, action and a bit of politics". The Oregonian . Advance Publications. June 2, 2009. Archived from the original on October 6, 2012. Retrieved January 25, 2010.
  6. 1 2 Roger Ebert (January 20, 2010). Extraordinary Measures Archived October 13, 2012, at the Wayback Machine . Sun Times. Accessed 2011-08-01.
  7. A. O. Scott (January 22, 2010). "Desperate Father's Plea to a Detached Scientist". NY Times.
  8. Jef Akst (January 22, 2010). "A review of Extraordinary Measures". The Scientist NewsBlog. Archived from the original on February 11, 2010. Retrieved February 1, 2010.
  9. "Proprietary Glycoprotein Technology Platform Will Advance Lysosomal Storage Disorder Programs". prnewswire.com. Archived from the original on May 9, 2012. Retrieved January 16, 2023.
  10. "FAQs". genzyme.com. Archived from the original on January 25, 2010.
  11. ""Extraordinary Measures" Father Coming to Norfolk " The Health Journal: Fitness, Nutrition, Wellness". Thehealthjournals.com. Archived from the original on March 28, 2012. Retrieved April 12, 2013.
  12. "Research Divisions". Ibms.sinica.edu.tw. Archived from the original on January 9, 2014. Retrieved April 12, 2013.
  13. "Extraordinary Measures (2010)". Rotten Tomatoes . Flixster . Retrieved May 10, 2020.
  14. "Extraordinary Measures: Reviews". Metacritic . CNET Networks. Archived from the original on January 24, 2010. Retrieved January 25, 2010.
  15. "Home". CinemaScore . Retrieved February 28, 2022.
  16. Corliss, Richard (February 1, 2010). "Extraordinary Measures: Sentiment Makes a Comeback". Time. Archived from the original on January 25, 2010.
  17. Scott, A. O. (January 22, 2010). "Desperate Father's Plea to a Detached Scientist". The New York Times.
  18. EmaxHealth. ""Extraordinary Measures" Brings Attention Pompe Disease". Archived from the original on April 16, 2021. Retrieved January 27, 2010.
  19. Peter Rainer (January 22, 2010). "Extraordinary Measures Movie Review".
  20. "A review of Extraordinary Measures". Archived from the original on May 28, 2010. Retrieved April 4, 2010.